Artisan Partners Limited Partnership Decreases Stock Holdings in Henry Schein, Inc. (NASDAQ:HSIC)

Artisan Partners Limited Partnership reduced its holdings in Henry Schein, Inc. (NASDAQ:HSIC) by 0.2% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 6,529,955 shares of the company’s stock after selling 16,063 shares during the period. Artisan Partners Limited Partnership owned approximately 5.24% of Henry Schein worth $451,873,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other large investors have also recently made changes to their positions in the business. FMR LLC grew its position in Henry Schein by 7.8% in the third quarter. FMR LLC now owns 3,280,890 shares of the company’s stock worth $239,177,000 after acquiring an additional 237,888 shares in the last quarter. Southpoint Capital Advisors LP boosted its holdings in shares of Henry Schein by 30.0% in the 3rd quarter. Southpoint Capital Advisors LP now owns 2,600,000 shares of the company’s stock worth $189,540,000 after purchasing an additional 600,000 shares during the period. Charles Schwab Investment Management Inc. raised its holdings in Henry Schein by 1.4% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 1,191,677 shares of the company’s stock valued at $82,464,000 after buying an additional 16,616 shares during the period. ING Groep NV raised its holdings in Henry Schein by 34.1% during the 4th quarter. ING Groep NV now owns 1,163,087 shares of the company’s stock valued at $80,486,000 after buying an additional 295,785 shares during the period. Finally, Stifel Financial Corp lifted its position in Henry Schein by 1.2% in the third quarter. Stifel Financial Corp now owns 1,122,455 shares of the company’s stock worth $81,827,000 after buying an additional 13,180 shares during the last quarter. 96.62% of the stock is currently owned by institutional investors.

Insider Transactions at Henry Schein

In related news, Director Philip A. Laskawy sold 2,604 shares of the business’s stock in a transaction that occurred on Wednesday, March 19th. The shares were sold at an average price of $71.04, for a total transaction of $184,988.16. Following the completion of the transaction, the director now owns 24,805 shares in the company, valued at $1,762,147.20. The trade was a 9.50 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, CEO Bradford C. Connett sold 4,036 shares of the firm’s stock in a transaction that occurred on Wednesday, March 19th. The shares were sold at an average price of $71.15, for a total transaction of $287,161.40. Following the completion of the sale, the chief executive officer now owns 62,688 shares of the company’s stock, valued at approximately $4,460,251.20. This trade represents a 6.05 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 1.14% of the company’s stock.

Henry Schein Stock Up 0.5 %

Shares of Henry Schein stock opened at $69.75 on Thursday. Henry Schein, Inc. has a 1 year low of $63.67 and a 1 year high of $82.49. The company has a debt-to-equity ratio of 0.46, a current ratio of 1.42 and a quick ratio of 0.82. The stock has a market cap of $8.66 billion, a price-to-earnings ratio of 28.70, a PEG ratio of 2.13 and a beta of 0.90. The firm’s 50-day moving average is $74.76 and its two-hundred day moving average is $72.63.

Henry Schein (NASDAQ:HSIC) last issued its quarterly earnings data on Tuesday, February 25th. The company reported $1.19 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.23 by ($0.04). The business had revenue of $3.19 billion for the quarter, compared to analysts’ expectations of $3.25 billion. Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. The business’s quarterly revenue was up 5.8% compared to the same quarter last year. During the same period in the previous year, the business earned $0.66 earnings per share. As a group, research analysts expect that Henry Schein, Inc. will post 4.74 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Several brokerages have recently weighed in on HSIC. Jefferies Financial Group increased their target price on shares of Henry Schein from $77.00 to $80.00 and gave the company a “hold” rating in a research note on Thursday, January 23rd. Mizuho initiated coverage on shares of Henry Schein in a research note on Wednesday, December 4th. They issued a “neutral” rating and a $75.00 price objective for the company. Barrington Research reaffirmed an “outperform” rating and set a $90.00 target price on shares of Henry Schein in a research note on Wednesday, February 26th. UBS Group decreased their price target on Henry Schein from $83.00 to $80.00 and set a “neutral” rating for the company in a research note on Wednesday, February 26th. Finally, Wells Fargo & Company assumed coverage on Henry Schein in a research report on Friday, February 14th. They issued an “equal weight” rating and a $80.00 price objective on the stock. Six equities research analysts have rated the stock with a hold rating, five have issued a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $81.10.

Henry Schein Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.